<DOC>
	<DOCNO>NCT01060267</DOCNO>
	<brief_summary>Objectives : Blood stomach &amp; oesophagus patient variceal bleed often obscure endoscopic view &amp; make endoscopic intervention difficult perform . Erythromycin , motilin agonist induces gastric empty . The aim study assess effect Erythromycin endoscopic visibility outcome .</brief_summary>
	<brief_title>Intravenous Erythromycin Before Endoscopy Patients With Variceal Bleeding : A Randomized , Double-Blind Trial</brief_title>
	<detailed_description>Methods : Adult patient liver cirrhosis stigma chronic liver disease present hematemesis melena within previous 12 hour randomize double blind trial receive either 125 mg erythromycin placebo 30 minute endoscopy . The primary end point endoscopic visibility assess objective scoring system &amp; mean endoscopy duration . Secondary end point need repeat endoscopy blood transfusion within 24 hour first endoscopy , endoscopy related complication length hospital stay .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Erythromycin</mesh_term>
	<mesh_term>Erythromycin Estolate</mesh_term>
	<mesh_term>Erythromycin Ethylsuccinate</mesh_term>
	<mesh_term>Erythromycin stearate</mesh_term>
	<mesh_term>Erythromycin lactobionate</mesh_term>
	<criteria>Adult patient liver cirrhosis stigma chronic liver disease present hematemesis melena within previous 12 hour Age &gt; 18 year Informed consent Hemodynamically stable patient time endoscopy resuscitation . Known allergy erythromycin Prior gastric lavage admission Current use antiarrhythmic drug Prior gastric surgery Previous history cardiac arrhythmia Concomitant use antihistaminic drug possible drug interaction erythromycin Prior use prokinetic agent Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>